Woroń J. Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?. Dermatology Review/Przegląd Dermatologiczny. 2025;112(1):27-37. doi:10.5114/dr.2025.152177.
APA
Woroń, J. (2025). Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?. Dermatology Review/Przegląd Dermatologiczny, 112(1), 27-37. https://doi.org/10.5114/dr.2025.152177
Chicago
Woroń, Jarosław. 2025. "Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?". Dermatology Review/Przegląd Dermatologiczny 112 (1): 27-37. doi:10.5114/dr.2025.152177.
Harvard
Woroń, J. (2025). Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?. Dermatology Review/Przegląd Dermatologiczny, 112(1), pp.27-37. https://doi.org/10.5114/dr.2025.152177
MLA
Woroń, Jarosław. "Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?." Dermatology Review/Przegląd Dermatologiczny, vol. 112, no. 1, 2025, pp. 27-37. doi:10.5114/dr.2025.152177.
Vancouver
Woroń J. Drug Interactions in Dermatological Practice. What Should be Considered when Treating Patients with Multimorbidity?. Dermatology Review/Przegląd Dermatologiczny. 2025;112(1):27-37. doi:10.5114/dr.2025.152177.